Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- VYT.MC
- Price
- 2.92
- Stock movement up
- +- (%)
- Company name
- Vytrus Biotech S.A.
- Exchange
- (MC ,
- Currency
- EUR )
- Sector
- Healthcare >Biotechnology
- Market cap
- 22.29M
- Ent value
- 24.82M
- Price/Sales
- 4.34
- Price/Book
- 4.69
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 26.83
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -10.98%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-04-05
DIVIDENDS
VYT.MC does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 26.83 |
| Price to OCF | 26.15 |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 4.34 |
| Price to Book | 4.69 |
| EV to Sales | 4.83 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 7.64M |
| EPS (TTM) | 0.12 |
| FCF per share (TTM) | -0.03 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 5.14M |
| Gross profit (TTM) | 4.24M |
| Operating income (TTM) | 870.12K |
| Net income (TTM) | 830.82K |
| EPS (TTM) | 0.12 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 82.54% |
| Operating margin (TTM) | 16.93% |
| Profit margin (TTM) | 16.17% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 724.62K |
| Net receivables | 506.06K |
| Total current assets | 1.68M |
| Goodwill | 0.00 |
| Intangible assets | 3.15M |
| Property, plant and equipment | 0.00 |
| Total assets | 8.00M |
| Accounts payable | 0.00 |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 1.27M |
| Total liabilities | 3.25M |
| Shareholder's equity | 4.75M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 852.67K |
| Capital expenditures (TTM) | 1.06M |
| Free cash flow (TTM) | -204.77K |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 17.48% |
| Return on Assets | 10.38% |
| Return on Invested Capital | 15.14% |
| Cash Return on Invested Capital | -3.73% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 2.92 |
| Daily high | 2.92 |
| Daily low | 2.92 |
| Daily Volume | 0K |
| All-time high | 4.00 |
| 1y analyst estimate | 3.28 |
| Beta | 0.00 |
| EPS (TTM) | 0.12 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| VYT.MC | S&P500 | |
| Current price drop from All-time high | -27.00% | -17.56% |
| Highest price drop | -53.50% | -56.47% |
| Date of highest drop | 2 Jan 2024 | 9 Mar 2009 |
| Avg drop from high | -26.48% | -11.07% |
| Avg time to new high | 100 days | 12 days |
| Max time to new high | 691 days | 1805 days |
COMPANY DETAILS
Marketcap
22.29M
Marketcap category
Small-cap
Description
Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells for the cosmetic sector primarily in Spain. It offers Nectaria Lithops, an active ingredient that biophysically optimizes the skin microenvironment and vitamin D levels; Photobiome a microbiota photoprotector; Olea Vitae cellular oil for ageing; Turmeria Zen for skin hydration and wrinkles on stressed profiles; Sensia Carota, a plant-based active that protects and prevents from the damage on sensitive and sensitized skins; Deobiome Noni, a biological deodorant; and Sarcoslim Re-Shape to reduce fat on tissue. The company also offers Capilia Longa for hair growth reactivation; Luminia Granatum for skin brightening;Elaya Renova a hair tensegrist; Kannabia Sense that stimulates the microbiota-skin-brain axis; Quora Noni to avoid the attack of skin harmful bacteria; Quora Noni biomics for rejuvenating the skin microbiota; Centella Reversa for facial complexion improvement; and Arabian Cotton for protection against photo-ageing. It sells its products to approximately 560 countries. Vytrus Biotech, S.A. was incorporated in 2009 and is based in Barcelona, Spain.
Employees
35
Website
Investor relations
-
SEC filings
CEO
Country
Spain
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found